An observational study in Gait Disorders, Neurologic, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2018-07-06.
Sponsored by University Hospital, Strasbourg, France · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Gait Disorders, Neurologic with a site in France — 4 open to participants now, 4 under way, none of them phase 3. Gait Disorders, Neurologic · France.
Among the 22 studies in Gait Disorders, Neurologic with a site in France, this one is one of 2 that started in 2017, is one of 8 observational ones, and was the 7th registered.
346 studies on the registry are indexed under Gait Disorders, Neurologic; 54 are open to participants now.
Browse Gait Disorders, Neurologic studies →4 of the 22 studies in Gait Disorders, Neurologic with a site in France are open now. Recruiting first, the newest first:
Clinique Les Trois Soleils · Sites in France
Ages 18+
FondationbHopale · Sites in France
Ages 18+
Wandercraft · Sites in France
Ages 18+
Fondation Ellen Poidatz · Sites in France
Ages 10–18
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 36 Gait Disorders, Neurologic studies recruiting now, 14 (39%) set no upper age limit and 19 (53%) stop at 75 or younger; 5 take children under 18; 5 take healthy volunteers.
This study: 50 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 52 across 78 observational studies indexed under Gait Disorders, Neurologic.
Median enrollment 27 across the 14 interventional studies, 45 across the 8 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 22 have an industry lead sponsor. The 10 most frequent:
University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.
University Hospital, Strasbourg, France has 1 study filed under Gait Disorders, Neurologic — fewer than ten, so there is no comparison to draw.
2 of the studies in Gait Disorders, Neurologic with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06327035Clinique Les Trois SoleilsEvolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center | 2027-03-01 |
| NCT06538974WandercraftAdherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population | 2027-07-02 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Gait Disorders, Neurologic with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The prevalence of neurodegenerative diseases will increase over the next decades driven by ageing population. It seems important to develop reliable, replicable and accessible diagnostic tools.
This is a prospective study whose objective is to study the spatio-temporal parameters of gait in patients with Alzheimer's and Lewy body diseases. 64 patients were included in this study. A comparison of the two pathologies was conducted, followed by an analysis based on four groups (mild, severe Alzheimer's disease, mild, severe Lewy body disease) and a study of the severity of the diseases. To study these parameters, we used the Gaitrite treadmill.
The analysis of spatio-temporal parameters of walking in Alzheimer's disease and Lewy body disease enables to identify discriminating variables between the two pathologies. The probability of suffering from an Alzheimer's disease decreases with the pace increase but increases with variations in length of the step, and with the rotation of the foot. While the probability of suffering from Lewy body disease increases with the pace, variations in the step duration, and the duration of double support.
These results are interesting but do not allow to establish a diagnostic score for these two diseases. The monitoring of the variations of these parameters at individual level would probably be more relevant and would enable to detect dual pathologies.
Patient over the age of 50 with a gait disorder
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
walking test
Time frame: 1 hour after inclusion
Plan to share: No
No publications or documents are linked to this record.
Started May 2017 (actual). Primary completion is estimated for Mar 2019, 22 months after the start.
Of 45 non-industry observational studies under Gait Disorders, Neurologic, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 46. This study's planned 22 months is above that.
Counting every sponsor, half of 46 studies reached it within 17 months; a quarter within 3 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →